ArticleCureus2024
Management of Antenatal Agitation in a Tertiary Care Center in Central India: A Secondary Analysis.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The presence of psychiatric symptoms in pregnancy is a common occurrence that requires swift and effective management to avoid harm to self, caregivers, staff, and, above all, the reliant fetus. However, there is a dearth of knowledge, practical guidelines, and research in the context of managing agitated states of antenatal patients. To bridge this critical knowledge gap, this research endeavors to illuminate the practices surrounding the management of agitated pregnant women with respect to psychiatric emergencies in a tertiary care hospital. Aims and objectives This study aims to study the pattern of psychotropic drugs used to manage agitation in antenatal patients in a tertiary care institute. Methods This retrospective record-based study was conducted in a tertiary care center in Central India to assess psychiatric referrals for the management of acute agitation in the department of obstetrics and gynecology. The consultation-liaison (CL) records of interdepartmental psychiatric referrals were assessed for a duration of one year between September 2022 and August 2023. Results The most frequently used treatment was intramuscular promethazine 25 mg, given to 32.20% of the participants. This was followed by intramuscular haloperidol 1.25 mg (14.69%) and tablet olanzapine 5 mg (10.17%). Tablet haloperidol 2.5 mg and intramuscular haloperidol 5 mg combined with promethazine 25 mg were each administered to 6.78% of the participants. Other treatments included tablet lorazepam 2 mg (6.21%), intramuscular lorazepam 2 mg (6.21%), intramuscular haloperidol 2.5 mg (9.60%), intravenous lorazepam 2 mg (2.26%), and tablet quetiapine 50 mg (1.13%). Verbal de-escalation was employed for 3.95% of the participants. None of the patients had to be restrained physically. Conclusion This study on antenatal agitation found promethazine followed by haloperidol as the most common treatment, used intramuscularly in low doses. Benzodiazepines like lorazepam were used sparingly, while verbal de-escalation proved effective in some cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.